No Data
We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate
Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research a
Cardiol Therapeutics Initiated at Buy by Roth MKM
Cardiol Therapeutics Initiated at Buy by Roth MKM
Roth MKM Initiates Cardiol Therapeutics(CRDL.US) With Buy Rating, Announces Target Price $10
Roth MKM analyst Jason Wittes initiates coverage on $Cardiol Therapeutics(CRDL.US)$ with a buy rating, and sets the target price at $10.According to TipRanks data, the analyst has a success rate of 50
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 P.m. EDT
Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research a
CCORF Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $8
CCORF analyst Edward Nash maintains $Cardiol Therapeutics(CRDL.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 38.1% and a to
Anil Datta : Price dropped and 10 time stocks traded any guess what happened?
Jaguar8OP Anil Datta: Always expect shorts to attack
Anil Datta Jaguar8OP: When shorts attack price normally goes down?
Jaguar8OP Anil Datta: Definitely.
Anil Datta Jaguar8OP: Good morning any other stocks you are fallowing Can you share please